Antibodies are typically named based on their target antigen, host species, or therapeutic application (e.g., Ofatumumab targets CD20 , Regdanvimab targets SARS-CoV-2 ). The identifier "Os01g0651100" does not align with established naming conventions for antibodies, which suggests it may refer to:
A hypothetical or unpublished antibody.
A gene/protein identifier misrepresented as an antibody.
A search of PubMed, PMC, and antibody-specific databases (e.g., The Antibody Society’s Therapeutic Antibodies Database , SAbDab ) yielded no results for this identifier. Key observations:
No matches in clinical trial registries or antibody engineering studies.
No alignment with known antibody formats (e.g., IgG, IgM) or applications (e.g., ELISA, flow cytometry ).
If "Os01g0651100" refers to a rice gene, an antibody against its encoded protein would require:
Sequence validation: Confirming the gene’s expression and protein product.
Antibody development: Custom production via hybridoma or recombinant methods .
No such data exists in the provided sources or public repositories like OAS .
The identifier may contain typographical errors or conflate terms (e.g., Os for Oryza sativa vs. a lab-specific code).
To validate the existence of "Os01g0651100 Antibody":
Consult genomic databases: Confirm the gene’s existence and protein product using resources like NCBI Gene or UniProt.
Contact antibody vendors: Inquire about custom antibodies targeting this gene (e.g., Thermo Fisher Scientific ).
Review patent databases: Explore filings for unpublished or proprietary antibodies.
The absence of peer-reviewed studies or commercial listings for this antibody suggests it is either:
In early-stage research (not yet published).
A miscommunication in nomenclature.
KEGG: osa:107281022
Os01g0651100 is a gene locus in rice (Oryza sativa) that encodes proteins involved in plant defense mechanisms. Antibodies against this target are developed to study protein expression, localization, and functional analysis in various rice tissues and under different stress conditions. Unlike simple molecular probes, these antibodies enable precise quantification of protein levels, visualization of subcellular localization, and investigation of protein-protein interactions through techniques such as Western blotting, immunoprecipitation, and immunofluorescence microscopy .
Sample preparation for Os01g0651100 antibody experiments should follow tissue-specific protocols. For rice leaf tissue, grind 100mg of fresh or frozen sample in liquid nitrogen, then extract proteins using a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1mM EDTA, 1% Triton X-100, and protease inhibitor cocktail. Centrifuge at 12,000g for 15 minutes at 4°C and collect the supernatant. Protein concentration should be determined using a Bradford assay before proceeding to immunodetection methods. For improved results, consider tissue-specific extraction modifications that account for different cellular compartments where Os01g0651100 protein may be localized .
Validating antibody specificity requires multiple complementary approaches. First, perform Western blot analysis using both wild-type and knockout/knockdown rice lines for Os01g0651100. A specific antibody will show reduced or absent signal in the genetic variants. Second, conduct pre-absorption tests by incubating the antibody with purified recombinant Os01g0651100 protein before immunodetection; specific binding should be significantly reduced. Third, compare the observed molecular weight and expression pattern with predicted values and published data. Finally, confirm specificity through immunoprecipitation followed by mass spectrometry analysis of the precipitated proteins .
Deep learning frameworks can substantially enhance Os01g0651100 antibody optimization by predicting binding affinities and epitope accessibility. Similar to approaches used for SARS-CoV-2 antibodies, geometric neural network models can be trained on antibody-antigen complex structures to extract interresidue interaction features and predict changes in binding affinity resulting from amino acid substitutions. For Os01g0651100 antibody design, researchers can:
Train models using plant antibody-antigen complexes to identify optimal complementarity-determining region (CDR) sequences
Simulate in silico ensembles of predicted complex structures with potential CDR mutations
Calculate estimated free energy changes (ΔΔG) for prospective antibody variants
Apply multiobjective optimization to target different Os01g0651100 variants or related proteins simultaneously
This computational approach dramatically expands the search space compared to traditional methods and facilitates efficient identification of high-affinity antibody candidates before experimental validation.
Developing cross-reactive antibodies for Os01g0651100 orthologs presents several challenges due to sequence variability across rice species. Researchers should:
Perform comprehensive sequence alignment of Os01g0651100 orthologs across targeted rice species to identify conserved regions
Design immunogens based on regions with 90%+ sequence identity
Consider structural epitope analysis to target conformationally conserved regions
Implement iterative optimization similar to the approach described for SARS-CoV-2 antibodies
The key methodological consideration is balancing specificity with cross-reactivity. To address this challenge, researchers can develop a panel of antibodies targeting different epitopes and characterize their binding profiles against recombinant proteins from multiple species. For optimal results, employ both phage display and hybridoma technologies in parallel, followed by comprehensive cross-reactivity testing against protein extracts from diverse rice varieties .
Os01g0651100 antibodies can significantly enhance single-cell analysis of rice tissues through several advanced methodologies:
Mass cytometry (CyTOF) - Conjugate Os01g0651100 antibodies with rare earth metals for high-dimensional protein profiling at single-cell resolution, enabling simultaneous detection of multiple markers in heterogeneous cell populations.
Imaging mass cytometry - Combine metal-labeled Os01g0651100 antibodies with tissue imaging to retain spatial information while analyzing protein expression patterns.
Single-cell Western blotting - Apply microfluidic platforms to perform Western blots on individual cells, revealing cell-to-cell variations in Os01g0651100 expression levels.
Proximity ligation assays - Detect protein-protein interactions involving Os01g0651100 at the single-molecule level within individual cells.
These approaches provide unprecedented insights into cell-specific Os01g0651100 expression patterns and functional roles, particularly during developmental processes or stress responses .
For successful immunoprecipitation (IP) of Os01g0651100 and its interacting partners, the following optimized protocol is recommended:
| Parameter | Recommended Condition | Alternative Option | Notes |
|---|---|---|---|
| Lysis Buffer | 50mM Tris-HCl pH 7.5, 150mM NaCl, 0.5% NP-40, 1mM EDTA, protease inhibitors | RIPA buffer for stronger interactions | NP-40 preserves weak interactions |
| Protein Amount | 500-1000μg total protein | 250μg minimum | Higher amounts increase detection sensitivity |
| Antibody Amount | 2-5μg per reaction | Up to 10μg for weak signals | Titration recommended for new antibodies |
| Incubation Time | Overnight at 4°C | 4 hours minimum | Longer incubation improves yield |
| Beads | Protein A/G magnetic beads | Agarose beads | Magnetic beads reduce background |
| Pre-clearing | 1 hour with beads only | Optional | Reduces non-specific binding |
| Washing Steps | 4× with decreasing salt concentration | 3× with constant buffer | Stringent washing improves specificity |
| Elution | SDS sample buffer at 95°C for 5 min | Native elution with peptide | Harsh elution maximizes yield |
For co-immunoprecipitation studies to identify Os01g0651100 interacting proteins, gentle crosslinking with 0.5-1% formaldehyde prior to cell lysis can preserve transient interactions. Following IP, mass spectrometry analysis of precipitated proteins can reveal novel interaction partners .
Optimizing Western blot protocols for Os01g0651100 detection requires addressing several critical parameters:
Sample preparation: Extract proteins using a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 5mM EDTA, 1% Triton X-100, 0.1% SDS, and protease inhibitors. Heat samples at 70°C for 10 minutes rather than 95°C to prevent potential aggregation.
Gel electrophoresis: Use 10-12% polyacrylamide gels for optimal resolution of Os01g0651100, with extended running time (90-120 minutes at 100V) to improve band separation.
Transfer conditions: Employ semi-dry transfer at 15V for 45 minutes or wet transfer at 30V overnight at 4°C using PVDF membrane (0.45μm pore size) pre-activated with methanol.
Blocking solution: 5% non-fat dry milk in TBST is recommended for general applications, while 3% BSA in TBST may provide lower background for phospho-specific antibodies.
Antibody dilution: Start with 1:1000 dilution for primary antibody incubation overnight at 4°C, then optimize based on signal-to-noise ratio.
Detection system: Enhanced chemiluminescence (ECL) provides sufficient sensitivity for most applications, while fluorescence-based detection offers superior quantitative analysis.
For challenging samples, consider enrichment techniques such as immunoprecipitation prior to Western blotting to increase sensitivity .
Successful immunohistochemical (IHC) localization of Os01g0651100 in rice tissues requires meticulous attention to tissue preparation and antibody application:
Fixation: Fix fresh rice tissues in 4% paraformaldehyde for 12-24 hours at 4°C. For reproductive tissues, consider using Farmer's fixative (3:1 ethanol:acetic acid) to better preserve morphology.
Tissue processing: Dehydrate tissues through an ethanol series, clear with xylene, and embed in paraffin. Section at 5-8μm thickness for optimal antibody penetration.
Antigen retrieval: Heat-induced epitope retrieval using 10mM sodium citrate buffer (pH 6.0) at 95°C for 20 minutes significantly improves antibody binding.
Blocking: Block with 5% normal serum (from the species in which the secondary antibody was raised) and 1% BSA in PBS for 1 hour at room temperature.
Primary antibody: Apply Os01g0651100 antibody at 1:100-1:500 dilution and incubate overnight at 4°C in a humidified chamber.
Detection system: Use a polymer-based detection system conjugated with horseradish peroxidase and DAB chromogen for permanent sections, or fluorescently labeled secondary antibodies for co-localization studies.
Controls: Always include negative controls (primary antibody omitted or non-specific IgG) and positive controls (tissues known to express Os01g0651100) in each experiment.
For dual labeling experiments, combine Os01g0651100 antibody with antibodies against organelle-specific markers to precisely determine subcellular localization .
Non-specific binding is a common challenge when working with plant antibodies. To address this issue with Os01g0651100 antibodies:
Increase blocking stringency: Extend blocking time to 2 hours and increase BSA concentration to 5% in blocking buffer. Adding 0.1% Tween-20 can further reduce non-specific interactions.
Optimize antibody concentration: Perform titration experiments to determine the minimum effective concentration that provides specific signal while minimizing background.
Pre-absorb antibody: Incubate diluted antibody with plant extract from Os01g0651100 knockout lines or with extracts from unrelated plant species to remove cross-reactive antibodies.
Modify washing conditions: Increase washing duration (5×10 minutes) and add up to 0.5M NaCl to the wash buffer to disrupt low-affinity non-specific interactions.
Use alternative detection systems: Switch from colorimetric to fluorescent detection methods, which often provide better signal-to-noise ratios.
For Western blotting specifically, cutting the membrane to include only the expected molecular weight region can eliminate non-specific bands that might complicate interpretation .
Inconsistencies between different experimental approaches (e.g., Western blot vs. immunohistochemistry) when using Os01g0651100 antibodies can be resolved through systematic analysis:
Epitope accessibility assessment: Different techniques expose different epitopes. Compare results with antibodies targeting distinct regions of Os01g0651100 to identify conformational dependencies.
Cross-validation with orthogonal methods: Confirm protein expression using RNA-seq or RT-qPCR data. For protein localization studies, compare antibody-based results with fluorescent protein fusion localization patterns.
Antibody validation matrix:
| Validation Method | Purpose | Implementation |
|---|---|---|
| Genetic controls | Confirm specificity | Compare wild-type vs. knockout/knockdown lines |
| Peptide competition | Verify epitope binding | Pre-incubate antibody with immunizing peptide |
| Isotype controls | Assess non-specific binding | Use matched isotype non-relevant antibody |
| Multi-antibody comparison | Validate results | Test multiple antibodies targeting different epitopes |
| Heterologous expression | Confirm detection | Test antibody against recombinant Os01g0651100 |
Technical consistency: Standardize sample preparation, antibody lots, incubation conditions, and detection methods across experiments to minimize technical variability.
Independent replication: Have different researchers or laboratories perform key experiments to confirm reproducibility .
Computational approaches significantly enhance Os01g0651100 antibody-based research through advanced analysis and optimization methods:
Epitope prediction and antibody design: Similar to strategies used for SARS-CoV-2 antibodies, apply deep learning models to predict optimal complementarity-determining region (CDR) sequences that maximize binding affinity and specificity. These models can:
Image analysis for localization studies:
Employ machine learning algorithms for automated segmentation of cellular compartments
Quantify co-localization with subcellular markers using Pearson's correlation coefficient and Manders' overlap coefficient
Implement object-based analysis for identifying protein clusters
Quantitative Western blot analysis:
Apply lane profile analysis with background subtraction
Normalize signal intensity to loading controls using regression-based methods
Perform statistical analysis to detect significant differences between experimental conditions
Interaction network analysis:
Integrate immunoprecipitation-mass spectrometry data with existing protein interaction databases
Apply graph theory algorithms to identify key interaction partners
Predict functional associations using gene ontology enrichment analysis
These computational approaches transform antibody-based research from qualitative to quantitative, enabling more rigorous hypothesis testing and data interpretation .
Single-domain antibodies (sdAbs or nanobodies) derived from camelid heavy-chain-only antibodies offer significant advantages for Os01g0651100 research that conventional antibodies cannot provide:
Enhanced epitope accessibility: Due to their small size (~15 kDa compared to ~150 kDa for conventional antibodies), sdAbs can access epitopes in protein complexes or membrane-bound contexts that are sterically hindered to larger antibodies.
Improved tissue penetration: SdAbs penetrate dense plant tissues more efficiently, enabling better visualization of Os01g0651100 in intact structures through techniques like whole-mount immunostaining.
Intrabody applications: SdAbs can be expressed intracellularly as "intrabodies" to track, modulate, or inhibit Os01g0651100 function in living cells, opening new avenues for functional studies.
Advanced imaging applications: SdAbs conjugated with fluorophores or electron-dense particles provide superior resolution in super-resolution microscopy or electron microscopy studies of Os01g0651100 localization.
Affinity optimization: Similar to the deep learning approach described for SARS-CoV-2 antibodies, sdAbs against Os01g0651100 can be computationally optimized for enhanced affinity and specificity through iterative mutation and testing cycles .
Emerging technologies for real-time monitoring of Os01g0651100 dynamics combine advanced antibody engineering with cutting-edge detection systems:
Antibody-based biosensors: Functionalize electrochemical or optical biosensors with Os01g0651100 antibodies to detect protein expression changes in near real-time from plant extracts or growth media.
FRET-based proximity sensors: Engineer antibody fragments conjugated with fluorescent proteins for Förster Resonance Energy Transfer (FRET) to monitor Os01g0651100 interactions with partner proteins in living cells.
Split-reporter complementation systems: Combine antibody-based recognition with split-reporter proteins (luciferase or fluorescent proteins) to visualize Os01g0651100 expression or interactions without requiring direct antibody detection in living tissues.
Microfluidic antibody arrays: Implement microfluidic platforms with immobilized Os01g0651100 antibodies for continuous sampling and monitoring of protein levels in plant exudates or growth media.
Antibody-conjugated quantum dots: Utilize quantum dot-conjugated Os01g0651100 antibodies for long-term tracking in living tissues with reduced photobleaching compared to conventional fluorophores.
These technologies will transform Os01g0651100 research from static snapshots to dynamic understanding of protein behavior under various developmental stages and environmental conditions .